Position in ESPR
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$36,251
New position
Shares Held
11,472
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Krilogy Financial LLC holds $3,083,818 across 8 Drug Manufacturers - Specialty & Generic names. ESPR ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,884 | $1,160,229 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,510 | $818,163 | |
| 3 | VTRS |
Viatris Inc
|
31,126 | $494,280 | |
| 4 | ZTS |
Zoetis Inc.
|
3,606 | $259,127 | |
| 5 | PRGO |
PERRIGO Co plc
|
11,976 | $124,430 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
26,348 | $110,925 | |
| 7 | EOLS |
Evolus, Inc.
|
11,587 | $80,413 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
This page
|
11,472 | $36,251 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,251 | 11,472 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||